{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:33:16Z","timestamp":1791822796020,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jjcc.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T13:13:34Z","timestamp":1573910014000},"page":"567-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The role of entirely subcutaneous ICD\u2122 systems in patients with dilated cardiomyopathy"],"prefix":"10.1016","volume":"75","author":[{"given":"Kevin","family":"Willy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Reinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"B\u00f6geholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ellermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"K\u00f6be","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1431-9886","authenticated-orcid":false,"given":"Gerrit","family":"Frommeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2019.10.005_bib0005","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0010","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","article-title":"Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry","volume":"35","author":"Lambiase","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0015","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jacc.2015.02.047","article-title":"Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE Study and EFFORTLESS Registry","volume":"65","author":"Burke","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0020","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.joa.2016.05.006","article-title":"Inappropriate shocks from a subcutaneous implantable cardioverter-defibrillator due to oversensing during periods of rate-related bundle branch block","volume":"33","author":"Sousa","year":"2017","journal-title":"J Arrhythm"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0030","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.hrthm.2015.02.035","article-title":"The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications","volume":"12","author":"van der Heijden","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/europace\/euy307","article-title":"Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-Analysis","volume":"21","author":"Segreti","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0040","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","article-title":"Implant and midterm outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study","volume":"70","author":"Boersma","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.hrthm.2015.08.039","article-title":"Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction","volume":"13","author":"Boersma","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0050","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.hrthm.2018.10.028","article-title":"Evaluation and management of ventricular tachycardia in patients with dilated cardiomyopathy","volume":"16","author":"Ebert","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0055","doi-asserted-by":"crossref","first-page":"e5312","DOI":"10.7717\/peerj.5312","article-title":"Comparison of ventricular tachyarrhythmia recurrence between ischemic cardiomyopathy and dilated cardiomyopathy: a retrospective study","volume":"6","author":"Fang","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0060","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12471-014-0595-z","article-title":"Follow-up of implantable cardioverter-defibrillator therapy: comparison of coronary artery disease and dilated cardiomyopathy","volume":"22","author":"Verhagen","year":"2014","journal-title":"Neth Heart J"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00392-013-0559-0","article-title":"Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry","volume":"102","author":"Wasmer","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0070","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0075","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s00380-018-01337-2","article-title":"Can we rely on Danish? Real-world data on patients with nonischemic cardiomyopathy from the German Device Registry","volume":"34","author":"Frommeyer","year":"2019","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0080","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.hrthm.2017.06.003","article-title":"Association of preprocedural cardiac magnetic resonance imaging with outcomes of ventricular tachycardia ablation in patients with idiopathic dilated cardiomyopathy","volume":"14","author":"Siontis","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0085","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/clc.22706","article-title":"Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study","volume":"40","author":"Duncker","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00392-016-1055-0","article-title":"Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems","volume":"106","author":"Kobe","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.hrthm.2016.11.025","article-title":"Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2008.05.019","article-title":"A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics","volume":"156","author":"Abraham","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0105","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/ejhf.1374","article-title":"Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction","volume":"21","author":"Anker","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0110","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/clc.22919","article-title":"Long-term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction","volume":"41","author":"Roger","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0115","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/europace\/euv299","article-title":"The learning curve associated with the introduction of the subcutaneous implantable defibrillator","volume":"18","author":"Knops","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0120","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/jce.13498","article-title":"Six-year follow-up of the initial Dutch subcutaneous implantable cardioverter-defibrillator cohort: Long-term complications, replacements, and battery longevity","volume":"29","author":"Quast","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0125","doi-asserted-by":"crossref","first-page":"f240","DOI":"10.1093\/europace\/euy083","article-title":"Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies","volume":"20","author":"Brouwer","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijcard.2015.05.135","article-title":"Inappropriate shocks in the subcutaneous ICD: incidence, predictors and management","volume":"195","author":"Olde Nordkamp","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2019.10.005_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2012.02.012","article-title":"Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy","volume":"163","author":"Olde Nordkamp","year":"2012","journal-title":"Am Heart J"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508719303351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508719303351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:01:56Z","timestamp":1760274116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508719303351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0914508719303351"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2019.10.005","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of entirely subcutaneous ICD\u2122 systems in patients with dilated cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}